Els Henckaerts is a co-founder of Tavira Therapeutics and is based in Herent. Since October 2019 she has been a professor at KU Leuven.
Before that she spent more than a decade at King's College London, where she joined as a research fellow in January 2008, became a lecturer in October 2012 and was appointed senior lecturer in October 2018, a position she held until October 2019.